Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021
Operating activities
Net earnings	$ 357,282	$ 262,106
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	121,301	125,095
(Gain) loss on disposal of property and equipment	(372)	(254)
Inventory write-offs for obsolescence	18,197	14,960
Deferred income taxes	8,843	(4,208)
Other	4,272	8,376
Change in U.S. transition tax liability	(14,757)	(14,757)
Change in repatriation tax liability	(25,201)	0
Net change in operating assets and liabilities	(151,773)	(80,866)
Net cash provided by operating activities	317,792	310,452
Investing activities
Capital expenditures	(172,175)	(118,156)
Proceeds from sale of property and equipment	472	1,257
Purchase of short-term investments	(182,079)	(55,491)
Maturity of short-term investments	132,892	126,171
Other investing activities	(199)	347
Net cash provided by (used in) investing activities	(221,089)	(45,872)
Financing activities
Repurchase of convertible debt instruments	0	(300)
Repurchase of common stock held in treasury	(54,671)	0
Distributions to noncontrolling interests	(741)	(800)
Cash withholding taxes paid when shares withheld for vested equity awards	(2,123)	(1,963)
Net cash provided by (used in) financing activities	(100,597)	(44,334)
Effect of exchange rate changes on cash and cash equivalents	(35,222)	(8,360)
Net increase (decrease) in cash and cash equivalents	(39,116)	211,886
Cash and cash equivalents at beginning of period	774,108	619,874
Cash and cash equivalents at end of period	734,992	831,760
Common Stock [Member]
Financing activities
Dividends paid to common stockholders	(39,433)	(37,823)
Class B Convertible Common Stock [Member]
Financing activities
Dividends paid to common stockholders	$ (3,629)	$ (3,448)